Welcome to Multibagg AI
Log in to access personalized features
Home
Dashboard
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Investor Presentation
Q2 FY25
Investor Presentation
Q4 FY24
Investor Presentation
Q3 FY24
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY24
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY24
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q1 FY24
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY23
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q3 FY23
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Discovery themes featuring this stock
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
| Symbol | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
1116.70 | 1,379 Cr | 22.81 | 3.45 | 0.27 | 13.08 | 16.21 | 8.67 | |
50.44 | 1,283 Cr | 31.72 | 0.83 | 0.00 | 2.58 | 7.27 | 1.23 | |
916.50 | 1,152 Cr | 15.20 | 0.64 | 1.50 | 4.07 | 5.39 | 3.36 | |
200.50 | 802 Cr | -14.03 | 0.95 | 0.50 | -5.59 | 1.07 | -2.79 | |
235.70 | 797 Cr | 22.88 | 1.79 | 0.00 | 10.95 | 13.62 | 5.05 | |
15.46 | 548 Cr | 15.20 | 0.75 | 1.29 | 1.58 | 6.54 | 1.23 | |
63.22 | 400 Cr | 10.10 | 0.91 | 0.00 | 8.63 | 10.37 | 4.41 |
Heranba Industries Ltd (HERANBA) is currently trading at 196.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Heranba Industries Limited is a leading agrochemical manufacturer specializing in synthetic pyrethroids and offering a wide range of crop protection and public health solutions. The company's nine-month revenue for FY25 was Rs. 1,075 crore, but global macroeconomic challenges and demand slowdowns have impacted growth, leading to significant fluctuations in product pricing, especially in exports. Despite a challenging market environment, Heranba is expanding its manufacturing capabilities, with ongoing capex at its Sarigam and Saykha facilities. The new production sites are expected to boost growth and diversify product offerings. Heranba has been actively focusing on expanding its formulation business, leveraging its technical production for higher value addition, which is increasingly contributing to revenue. The company is strategically positioning itself to benefit from the China Plus One strategy, expecting future growth from new registrations in export markets, especially with its recent expansion initiatives.
Over the past 52 weeks, Heranba Industries Ltd has traded between a low of ₹193.15 and a high of ₹403.40. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Heranba Industries Ltd has a market capitalization of approximately 802.27. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Heranba Industries Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -14.03 and operates in the Agro Chemicals sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 802.27 Cr, Heranba Industries Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Heranba Industries Ltd operates in the Agro Chemicals sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Heranba Industries Ltd is -14.03. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Legal Proceedings
Haresh Petrochem filed a Section 9 IBC petition on Feb 26, 2026 against Heranba Organics Pvt Ltd (100% subsidiary) claiming ~Rs 1.70 Cr with outstanding ~Rs 93.90 lakh; HOPL expects amicable resolution; may affect consolidated results.
Legal Proceedings
Haresh Petrochem filed a Section 9 IBC petition on Feb 26, 2026 against Heranba's 100% subsidiary Heranba Organics (HOPL) for ~Rs 1.70 crore (outstanding ~Rs 93.90 lakh); HOPL cites a quality dispute, hearing set Feb 27, 2026 and expects amicable resolution.
Bearish
5
Neutral
2
Bullish
7
Bearish
37
Neutral
2
Bullish
7
Bearish
32
Neutral
0
Bullish
0
Heranba Industries Limited is a leading agrochemical manufacturer specializing in synthetic pyrethroids and offering a wide range of crop protection and public health solutions.
The company's nine-month revenue for FY25 was Rs. 1,075 crore, but global macroeconomic challenges and demand slowdowns have impacted growth, leading to significant fluctuations in product pricing, especially in exports.
Despite a challenging market environment, Heranba is expanding its manufacturing capabilities, with ongoing capex at its Sarigam and Saykha facilities. The new production sites are expected to boost growth and diversify product offerings.
Heranba has been actively focusing on expanding its formulation business, leveraging its technical production for higher value addition, which is increasingly contributing to revenue.
The company is strategically positioning itself to benefit from the China Plus One strategy, expecting future growth from new registrations in export markets, especially with its recent expansion initiatives.
Agro Chemicals
Pesticides / Agrochemicals - Indian - Large
802 Cr
Low Risk
-14.0
26.4
—
1.0
403.40
199.00
Sales CAGR
Profit CAGR
ROE
ROCE
